Table 1 Intensity and extent of p53 immunopositivity in CNS embryonal tumors
Case | Tumor Subtype | p53 Intensity | p53 Positive Cells |
|---|---|---|---|
1 | Classic MB | 1 | 5 to 25% |
2 | Classic MB | 1 | 5 to 25% |
3 | Classic MB | 1 | 5 to 25% |
4 | Classic MB | 1 | 5 to 25% |
5 | Classic MB | 1 | 5 to 25% |
6 | Nodular MB | 1 | 5 to 25% |
7 | Nodular MB | 1 | 5 to 25% |
8 | Nodular MB | 1 | 5 to 25% |
9 | Moderately Anaplastic MB | 1 | 5 to 25% |
10 | Moderately Anaplastic MB | 1 | 5 to 25% |
11 | Moderately Anaplastic MB | 1 | 5 to 25% |
12 | Moderately Anaplastic MB | 1 | 5 to 25% |
13 | Moderately Anaplastic MB | 1 | 5 to 25% |
14 | Moderately Anaplastic MB | 1 | 5 to 25% |
15 | Severely Anaplastic MB | 2 | 51 to 75% |
16 | Severely Anaplastic MB | 2 | 51 to 75% |
17 | Severely Anaplastic MB | 2 | 26 to 50% |
18 | sPNET | 1 | 5 to 25% |
19 | sPNET | 1 | 5 to 25% |
20 | sPNET | 1 | 5 to 25% |
21 | sPNET | 2 | 5 to 25% |
22 | sPNET/Medulloepithelioma | 1 | 5 to 25% |
23A | sPNET/Medulloepithelioma | 2 | 51 to 75% |
23B | sPNET/Medulloepithelioma | 2 | 76 to 100% |
24 | AT/RT | 1 | 5 to 25% |
25 | AT/RT | 2 | 26 to 50% |